February 2026
The recombinant proteins market size was evaluated at USD 3.97 billion in 2025 and is predicted to surpass around USD 12.44 billion by 2035, growing at a CAGR of 12.10% from 2026 to 2035.
June 2026
The global recombinant DNA technology market size was valued at USD 913.36 billion in 2025 and is expected to hit around USD 1,719.89 billion by 2035, at a CAGR of 6.53%.
May 2026
The global PEGylation proteins market size accounted for USD 2.39 billion in 2025 and is projected to hit around USD 6.65 billion by 2035 with a CAGR of 10.78%.
January 2026
The global recombinant cell culture supplements market size was evaluated at USD 1.13 billion in 2025 and is predicted to hit around USD 3.89 billion by 2035, growing at a CAGR of 13.16%.
August 2025
The global PEGylation proteins technology market size was evaluated at USD 4.56 billion in 2024 and is predicted to hit around USD 9.17 billion by 2034, growing at a CAGR of 7.24%.
February 2025
The global recombinant chemicals market size was estimated at USD 18.31 billion in 2024 and is expected to hit around USD 27.95 billion by 2034, at a CAGR of 4.32%.
July 2024
The global recombinant antibodies market size was estimated at USD 12.40 billion in 2023 and is projected to surpass around USD 23.34 billion by 2033 with a CAGR of 6.53%.
August 2025
The global human chorionic gonadotropin market size is projected to surge around USD 2.94 billion by 2034 from USD 2.15 billion in 2024, with a CAGR of 3.20%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com